IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)
Barlesi, F., Nishio, M., Cobo, M., Steele, N., Paramonov, V., Parente, B., Dear, R., Berard, H., Peled, N., Seneviratne, L.C., Baldini, E., Watanabe, S., Goto, K., Mendus, D., Patel, H., Deng, Y., Kowanetz, M., Hoang, T., Lin, W., Papadimitrakopoulou, V.A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
LBA1Fast progression in patients treated with a checkpoint inhibitor (cpi) vs chemotherapy in OAK, a phase III trial of atezolizumab (atezo) vs docetaxel (doc) in 2L+ NSCLC
Gandara, D R, Reck, M, Morris, S, Cardona, A, Mendus, D, Ballinger, M, Rittmeyer, A
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Fast progression in patients treated with a checkpoint inhibitor (cpi) vs chemotherapy in OAK, a phase III trial of atezolizumab (atezo) vs docetaxel (doc) in 2L+ NSCLC
Gandara, D.R., Reck, M., Morris, S., Cardona, A., Mendus, D., Ballinger, M., Rittmeyer, A.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer
Wainberg, Z., Matos, I., Delord, J., Cassier, P., Gil-Martin, M., Kim, T., LoRusso, P., Bahleda, R., Italiano, A., Mendus, D., Hoang, T., Xue, C., Wen, X., Carvalho, O., Pham, T., Patil, N., Meng, R., Bendell, J., Cervantes, A., Cho, B.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
375O Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC
Nishio, M., Barlesi, F., Ball, S., Bordoni, R., Cobo, M., Dubray-Longeras, P., Goldschmidt, J., Novello, S., Orlandi, F.J., Sanborn, R., Szalai, Z., Ursol, G., Mendus, D., Wang, L., Wen, X., McCleland, M., Hoang, T., Phan, S., Socinski, M.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
LBA2 Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab + atezolizumab (TA) versus placebo + atezolizumab (PA) as first-line treatment for PD-L1+ NSCLC
Cho, B.C., Rodriguez-Abreu, D., Hussein, M., Cobo, M., Patel, A., Secen, N., Gerstner, G., Kim, D-W., Lee, Y-G., Su, W-C., Huang, E., Patil, N., Huang, M., Zhang, Z., Wen, X., Mendus, D., Hoang, T., Meng, R., Johnson, M.L.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
Papadimitrakopoulou, V., Cobo, M., Bordoni, R., Dubray-Longeras, P., Szalai, Z., Ursol, G., Novello, S., Orlandi, F., Ball, S., Goldschmidt, J., Sanborn, R., Hoang, T., Mendus, D., Deng, Y., Kowanetz, M., Wen, X., Lin, W., Sandler, A., Nishio, M.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
LBA54IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)
Barlesi, F, Nishio, M, Cobo, M, Steele, N, Paramonov, V, Parente, B, Dear, R, Berard, H, Peled, N, Seneviratne, L C, Baldini, E, Watanabe, S, Goto, K, Mendus, D, Patel, H, Deng, Y, Kowanetz, M, Hoang, T, Lin, W, Papadimitrakopoulou, V A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article